跳至主要内容
临床试验/EUCTR2015-001092-49-SE
EUCTR2015-001092-49-SE进行中(未招募)不适用

Valproic acid regulation of plasma PAI-1

Sahlgrenska Akademien Wallenberglaboratoriet0 个研究点开始时间: 2015年3月30日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • For all subjects:
  • 1.Subect has given informed consent
  • 2.Men and women aged 20 -85 years
  • 3.Non smoker
  • Additional for patients with coronary artery disease:
  • 4.Pronounced atherosclerosis
  • 5.Treatment for acute myocardial infarction for more than a year ago
  • 6.Only Trombyl (no other anticoagulant therapy)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • 2.BMI (body mass index) >35 kg / m²
  • 3.Epilepsy
  • 4.Uncontrolled hypertension
  • 5.Malignancy
  • 6.Mental disorder
  • 7.Alcoholism
  • 8.All forms of chronic illness with medications that are contraindicated to combine with Ergenyl
  • 9.Acute infection
  • 10.Difficulties in implementing the study with regard to the inability to lie still on a gurney because of the general condition or obvious difficulty with putting vein / artery catheter
  • 11.Interaction with Ergenyl
  • 12.Known hypersensitivity to valproic acid or other component included
  • 13.Ongoing or planned pregnancy within the next 3 months
  • 14.Breastfeeding women
  • 15.Suspected or actual inability to perceive the study of information and instruction

研究者

发起方
Sahlgrenska Akademien Wallenberglaboratoriet

相似试验